| Fee income | |
| Operating expenses | 865.59K |
| Research and development | 503.57K |
| Operating Expenses, Total | 1.37M |
| Operating loss | -1.12M |
| Net investment income | 7.97K |
| Net loss | -1.12M |
| Basic and diluted net loss per common share (in dollars per share) | -0.05 |
| Basic and diluted weighted average number of common shares outstanding (in shares) | |